| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/18/1996 | WO1996021734A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | WO1996021727A1 Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens |
| 07/18/1996 | WO1996021724A1 Human deoxycytidine kinase 2 |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021356A1 Methods and compositions for inducing mucosal immune responses |
| 07/18/1996 | WO1996009395A3 Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | CA2209990A1 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/18/1996 | CA2209064A1 Methods and compositions for inducing mucosal immune responses |
| 07/17/1996 | EP0721782A2 Influenza vaccine containing pertussis toxin |
| 07/17/1996 | EP0721510A1 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 07/17/1996 | EP0721506A1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/17/1996 | EP0721505A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/1996 | EP0721504A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
| 07/17/1996 | EP0721470A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/17/1996 | EP0721469A1 Anti-gp39 antibodies and uses therefor |
| 07/17/1996 | EP0721466A1 Protective antigens against parasites |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/17/1996 | EP0721463A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721350A1 Intracellular immunization |
| 07/17/1996 | EP0721346A1 Methods for inducing antigen-specific t cell tolerance |
| 07/17/1996 | EP0721345A1 Prostatic cancer vaccine |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721341A1 Cloning and characterization of the complete mage-1 gene |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | EP0506868B1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/17/1996 | EP0481058B1 Human lymphoid tissue in an immunocompromised host |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1126759A Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 07/17/1996 | CN1126617A High-grade life-prolonging health oral liquid |
| 07/17/1996 | CN1032315C Method for producing hepatitis B virus proteins in yeast |
| 07/16/1996 | US5536647 Nucleic acids and vector encoding HMFQ polypeptide, transfected host, fusion proteins thereof, compositions thereof and methods of use thereof |
| 07/16/1996 | US5536642 Cell-associated interleukin-2 receptor a expression |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/16/1996 | US5536497 Fimbrial polypeptides useful in the prevention of periodontitis |
| 07/16/1996 | US5536496 Pasteurella multocida toxoid vaccines |
| 07/11/1996 | WO1996021034A1 Avian recombinant live vaccine |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021015A2 Combination gene delivery vehicles |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020958A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020953A2 Synthetic multimeric peptide with delta hepatitis virus antigenic activity |
| 07/11/1996 | WO1996020731A1 Direct administration of gene delivery vehicles at multiple sites |
| 07/11/1996 | WO1996020729A1 Decreased mortality of severe acute pancreatitis following proximal cytokine blockade |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020727A1 Chicken anaemia agent broiler vaccine |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996007745A3 Mycobacteria functional screening and/or expression vectors |
| 07/11/1996 | CA2208411A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | CA2208016A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/10/1996 | EP0721015A1 Monoclonal antibody that induces apoptosis |
| 07/10/1996 | EP0720654A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 07/10/1996 | EP0720653A1 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
| 07/10/1996 | EP0720624A1 Retargeting antibodies |
| 07/10/1996 | EP0720622A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 07/10/1996 | EP0720485A1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0370090B1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
| 07/10/1996 | CN1126494A Method for recombinant production of biologically active polypeptides |
| 07/10/1996 | CN1126492A Recombinant antigens from mumps virus and their use in vaccines |
| 07/10/1996 | CN1126491A Intracellular binding proteins and use thereof |
| 07/10/1996 | CN1032236C Process for preparing liposomes that provide thymic dependent help to weak vaccine antigens |
| 07/09/1996 | US5534540 Crosslinking and discoloration inhibition; preserving foods; aging resistance |
| 07/09/1996 | US5534439 Isolated DNA of human papillomavirus type 55 (HPV55) |
| 07/09/1996 | US5534413 Adherent and invasive mycoplasma |
| 07/09/1996 | US5534411 Monoclonal IgA antibody specific for respiratory syncytial virus, a hybridoma cell line that produces this antibody amd methods of using the antibody to diagnose RSV infection |
| 07/09/1996 | US5534410 TATA-binding protein associated factors drug screens |
| 07/09/1996 | US5534405 Antibodies, diagnostic systems and methods for assaying HBxAg |
| 07/09/1996 | US5534258 Polypeptides to prevent atherosclerotic plaque |
| 07/09/1996 | US5534257 Genetic engineering; insertion of foreign peptide epitope; vaccines |
| 07/09/1996 | US5534256 Vaccines, veterinary medicine |
| 07/09/1996 | US5534254 Biosynthetic binding proteins for immuno-targeting |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/09/1996 | CA1338441C Expression of immunologically active proteins of human .beta.-lympho tropic virus |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020273A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/04/1996 | WO1996020222A1 Novel cyclodextrin-derivatives and methods for the preparation thereof |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 07/04/1996 | WO1996020217A1 Monoclonal antibody |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020213A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | WO1996020013A1 Improvements in or relating to endometrial function |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996020008A1 Vaccine adjuvants |
| 07/04/1996 | WO1996020007A1 Vaccine adjuvants |
| 07/04/1996 | WO1996020006A1 Vaccine against aids comprising a peptide sequence of hiv |
| 07/04/1996 | WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | WO1996011664A3 NSK2 a muscle receptor tyrosine kinase |
| 07/04/1996 | CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208446A1 Improvements in or relating to endometrial function |
| 07/04/1996 | CA2208329A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |